Effects of luteinizing hormone on peroxisome proliferator-activated receptor γ in the rat ovary before and after the gonadotropin surge

Reproduction

Volumn 131, Issue 1, 2006, Pages 93-101

  Banerjee, Jayeeta ^a   Komar, Carolyn M ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOHEXIMIDE; GONADOTROPIN; LUTEINIZING HORMONE; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CULTURE MEDIUM; CUMULUS OOPHORUS; DEVELOPMENTAL STAGE; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GRANULOSA CELL; HORMONE ACTION; HORMONE RELEASE; IMMUNOBLOTTING; IMMUNOLOCALIZATION; INCUBATION TIME; NONHUMAN; OVARY; OVULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RAT;

ANIMALS; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOHEXIMIDE; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS, EQUINE; GRANULOSA CELLS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOQUINOLINES; LUTEINIZING HORMONE; OVARY; PHOSPHORYLATION; PPAR GAMMA; PROTEIN SYNTHESIS INHIBITORS; RATS; RNA, MESSENGER; SULFONAMIDES;

ANIMALIA;

EID: 32544445171     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/rep.1.00730     Document Type: Article

References (53)

1. Adams M, Reginato MJ, Shao D, Lazar MA & Chatterjee VK 1997 Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. Journal of Biological Chemistry 272 5128-5132.
2. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A & Evans RM 1999 PPARγ is required for placental, cardiac, and adipose tissue development. Molecular Cell 4 585-595.
3. Berger J & Moller DE 2002 The mechanisms of action of PPARs. Annual Review of Medicine 53 409-435.
4. Braissant O, Foufelle F, Scotto C & Wahli W 1996 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β and -γ in the adult rat. Endocrinology 137 354-366.
5. Butts BD, Tran NL & Briehl MM 2004 Identification of a functional peroxisome proliferator activated receptor response element in the 3′ untranslated region of the human bcl-2 gene. International Journal of Oncology 24 1305-1310.
6. Camp HS, Tafuri SR & Leff T 1999 c-jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity. Endocrinology 140 392-397.
7. Cui Y, Miyoshi K, Claudio E, Siebenlist UK, Gonzalez FJ, Flaws J, Wagner K-U & Hennighausen L 2002 Loss of the peroxisome proliferation-activated receptor gamma (PPARγ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. Journal of Biological Chemistry 277 17830-17835.
8. Davis JS 1994 Mechanisms of hormone action: luteinizing hormone receptors and second-messenger pathways. Current Opinion in Obstetrics and Gynecology 6 254-261.
9. Davis JS, Weakland LL, West LA & Farese RV 1986 Luteinizing hormone stimulates the formation of inositol trisphosphate and cyclic AMP in rat granulosa cells. Evidence for phospholipase C generated second messengers in the action of luteinizing hormone. Biochemistry Journal 238 597-604.
10. Debril M-B, Renaud J-P, Fajas L & Auwerx J 2001 The pleiotropic functions of peroxisome proliferator-activated receptor γ. Journal of Molecular Medicine 79 30-47.
11. Escher P & Wahli W 2000 Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutation Research 448 121-138.
12. Fan W, Yanase T, Morinaga H, Mu Y-M, Nomura M, Okabe T, Goto K, Harada N & Nawata H 2005 Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB. Endocrinology 146 85-92.
13. i dose response. Endocrinology 139 3606-3612.
14. Floyd ZE & Stephens JM 2002 Interferon-γ-mediated activation and ubiquitin-proteasome-dependent degradation of PPARγ in adipocytes. Journal of Biological Chemistry 277 4062-4068.
15. Froment P, Fabre S, Dupont J, Pisslet C, Chesneau D, Staels B & Monget P 2003 Expression and functional role of peroxisome proliferator-activated receptor γ in ovarian folliculogenesis in the sheep. Biology of Reproduction 69 1665-1674.
16. Hauser S, Adelmant G, Sarraf P, Wright HM, Mueller E & Spiegelman BM 2000 Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation. Journal of Biological Chemistry 275 18527-18533.
17. Hickey GJ, Chen S, Besman M, Shively J, Hall P, Gaddy-Kurten D & Richards JS 1988 Hormonal regulation, tissue distribution, and content of aromatase cytochrome P450 messenger ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea: relationship to estradiol biosynthesis. Endocrinology 122 1426-1436.
18. Hsi LC, Wilson L, Nixon J & Eling TE 2001 15-Lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor (via the MAPK signaling pathway. Journal of Biological Chemistry 246 34545-34552.
19. Hu E, Kim JB, Sarraf P & Spiegelman BM 1996 Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274 2100-2103.
20. Jo M, Komar CM & Fortune JE 2002 Gonadotropin surge induces two separate increases in expression of progesterone receptor in bovine periovulatory follicles. Biology of Reproduction 67 1981-1988.
21. Komar CM & Curry TE Jr 2003 Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor γ and P450 side chain cleavage in the rat ovary. Biology of Reproduction 69 549-555.
22. Komar CM, Braissant O, Wahli W & Curry TE Jr 2001 Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 142 4831-4838.
23. Lambe KG & Tugwood JD 1996 A human peroxisome-proliferator-activated receptor-γ is activated by inducers of adipogenesis, including thiazolidinedione drugs. European Journal of Biochemistry 239 1-7.
24. Laurora S, Pizzimenti S, Briatore F, Fraioli A, Maggio M, Reffo P, Ferretti C, Dianzani U & Barrera G 2003 Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. Journal of Pharmacology and Experimental Therapeutics 305 932-942.
25. Löhrke B, Viergutz T, Shahi SK, Pöhland R, Wollenhaupt K, Goldammer T, Walzel H & Kanitz W 1998 Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor γ in lutein cells. Journal of Endocrinology 159 429-439.
26. Lovekamp-Swan T & Chaffin CL 2005 The peroxisome proliferator-activated receptor γ ligand troglitazone induces apoptosis and p53 in rat granulosa cells. Molecular and Cellular Endocrinology 233 15-24.
27. Lovekamp-Swan T, Jetten AM & Davis BJ 2003 Dual activation of PPARα and PPARγ by mono-(2-ethylheyl) phthalate in rat ovarian granulosa cells. Molecular and Cellular Endocrinology 201 133-141.
28. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM & O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes and Development 9 2266-2278.
29. Mann JS, Kindy MS, Edwards DR & Curry TE Jr 1991 Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries. Endocrinology 128 1825-1832.
30. Marx N, Sukhova GK, Murphy C, Libby P & Plutzky J 1998 Macrophages in human atheroma contain PPARγ. American Journal of Pathology 153 17-23.
31. Marx N, Schönbeck U, Lazar MA, Libby P & Plutzky J 1999 Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circulation Research 83 1097-1103.
32. Meade E, McIntyre T, Zimmerman G & Prescott S 1999 Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. Journal of Biological Chemistry 274 8328-8334.
33. Mohan M, Malayer JR, Geisert RD & Morgan GL 2002 Expression patterns of retinoid X receptors, retinaldehyde dehydrogenase, and peroxisome proliferator activated receptor gamma in bovine preattachment embryos. Biology of Reproduction 66 692-700.
34. Morris JK & Richards JS 1993 Hormone induction of luteinization and prostaglandin endoperoxide synthase-2 involves multiple cellular signaling pathways. Endocrinology 133 770-779.
35. Mu Y-M, Yanase T, Nishi Y, Waseda N, Oda T, Tanake A, Takayanagi R & Nawata H 2000 Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Biochemical and Biophysical Research Communications 271 710-713.
36. Ohshima T, Koga H & Shimotohno K 2004 Transcriptional activity of peroxisome proliferator-activated receptor γ is modulated by SUMO-1 modification. Journal of Biological Chemistry 279 29551-29557.
37. Park O-K & Mayo KE 1991 Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge. Molecular Endocrinology 5 967-978.
38. Peng X-R, Hsueh AJW, La Polt PS, Bjersing L & Ny T 1991 Localization of luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell types during follicle development and ovulation. Endocrinology 129 3200-3207.
39. Reginato MJ, Krakow SL, Bailey ST & Lazar MA 1998 Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. Journal of Biological Chemistry 273 1855-1858.
40. Richards JS 1994 Hormonal control of gene expression in the ovary. Endocrine Reviews 15 725-751.
41. Richards JS, Russell DL, Robker RL, Dajee M & Alliston TN 1998 Molecular mechanisms of ovulation and luteinization. Molecular and Cellular Endocrinology 145 47-54.
42. Kip1. Molecular Endocrinology 12 924-940.
43. Robker RL, Russell DL, Espey LL, Lydon JP, O'Malley BW & Richards JS 2000 Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. PNAS 97 4689-4694.
44. Schoppe PD, Garmey JC & Veldhuis JD 2002 Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biology of Reproduction 66 190-198.
45. Shao R, Markström E, Friberg PA, Johansson M & Billig H 2003 Expression of progesterone receptor (PF) A and B isoforms in mouse granulosa cells: stage-dependent PR-mediated regulation of apoptosis and cell proliferation. Biology of Reproduction 68 914-921.
46. Shibuya A, Wada K, Nakajima A, Saeki M, Katayama K, Mayumi T, Kadowaki T, Niwa H & Kamisaki Y 2002 Nitration of PPARγ inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264. FEBS Letters 525 43-47.
47. Shu H, Wong B, Zhou G, Li Y, Berger J, Woods J, Wright S & Cai T-Q 2000 Activation of PPARα or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. Biochemical and Biophysical Research Communications 267 345-349.
48. 2: genetic mapping and differential expression of the two isoforms. Biochemical and Biophysical Research Communications 239 857-861.
49. Swan T & Chaffin C 2004 The PPARγ ligand troglitazone induces p53 and apoptosis in rat ovarian granulosa cells. Biology of Reproduction Special issue 139.
50. Theocharis S, Margeli A, Vielh P & Kouraklis G 2004 Peroxisome proliferator-activated receptor-γ ligands as cell-cycle modulators. Cancer Treatment Reviews 30 545-554.
51. Veldhuis JD, Zhang G & Garmey JC 2002 Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro. Journal of Clinical Endocrinology and Metabolism 87 1129-1133.
52. Yamakawa K, Hosoi M, Koyama H, Tanaka S, Fukumoto S, Morii H & Nishizawa Y 2000 Peroxisome proliferator-activated receptor-γ agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. Biochemical and Biophysical Research Communications 271 571-574.
53. Yee J, Kuncio GS, Bhandari B, Shihab FS & Neilson EG 1997 Identification of promoter activity and differential expression of transcripts encoding the murine stromelysin-1 gene in renal cells. Kidney International 52 120-129.